Towards noninvasive diagnosis of malaria
迈向疟疾的无创诊断
基本信息
- 批准号:10005582
- 负责人:
- 金额:$ 18.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-18 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:AfricaAftercareAntimalarialsAreaAsiaAustraliaBiological MarkersBlood CirculationBlood specimenBreath TestsCenters for Disease Control and Prevention (U.S.)Cessation of lifeCharacteristicsChildChildhoodClinicalClinical ResearchCulicidaeDataDetectionDevelopmentDevicesDiagnosisDiagnosticDiagnostic testsEnrollmentEnsureExhalationFalciparum MalariaGene DeletionGlobal ChangeGoalsHRP-2 proteinHealth CampaignInfectionInterdisciplinary StudyInvestigationInvestmentsKenyaLaboratory ResearchLeadLocationMachine LearningMalariaMalawiMass Spectrum AnalysisMedical ResearchMolecularNoseParasitemiaParasitesParasitologyPersonsPilot ProjectsPlasmodium falciparumPublic HealthReportingReproducibilityResearchResearch InstituteRiskTechniquesTechnologyTestingTranslatingbasebiomarker discoverybreath compositioncandidate markerclinical Diagnosiscohortcostdensitydiagnostic biomarkerexperienceglobal healthimprovedinnovationmalaria infectionnoninvasive diagnosispediatric patientsportabilityresponsesensorspecific biomarkerssuccesstooltransmission processtreatment responsevolatile organic compound
项目摘要
PROJECT SUMMARY
Plasmodium falciparum causes the deadliest form of malaria, which is responsible for nearly one million deaths
annually. There is currently no perfect test to detect if a person has malaria. This is because all available tests
have challenges and are all based on testing a blood sample. We have identified volatile organic compounds
that are produced by the malaria parasite in culture. In a recent pilot study that was conducted in Lilongwe, Ma-
lawi, we found that similar compounds are also present in the breath of children who have uncomplicated falci-
parum malaria. We also observed a global change in the breath profile of children with malaria. The objectives
of this proposal are to identify candidate biomarkers of malaria, with the long-term goal to develop a new non-
invasive test to diagnose clinical malaria infection. Supported by our strong preliminary data that indicate that
this strategy will be successful, our objectives will be met through two specific aims: 1) determine reproducible
changes in the breath composition in response to malaria infection, in an independent location. 2) Relate
breath changes with parasite development stages. Our approach is innovative, since we will enroll naturally
infected children in the field. Children harbor the highest parasite and gametocyte densities. The proposed re-
search is significant, because we will progress in development of new, much-needed malaria diagnostic tool
that will not rely on blood samples.
项目摘要
恶性疟原虫引起最致命的疟疾形式,疟疾造成近100万人死亡
每年。目前没有完美的测试来检测一个人是否患有疟疾。这是因为所有可用的测试
面临挑战,全部基于测试血液样本。我们已经确定了挥发性有机化合物
疟疾在培养物中产生的。在最近在Lilongwe进行的一项试点研究中
Lawi,我们发现在不复杂的儿童的呼吸中也存在类似的化合物。
疟疾疟疾。我们还观察到疟疾儿童的呼吸形象发生了全球变化。目标
该提议的内容是确定疟疾的候选生物标志物,其长期目标是开发新的非 -
侵入性测试以诊断临床疟疾感染。在我们强大的初步数据的支持下,表明
该策略将成功,我们的目标将通过两个具体目标实现:1)确定可重复性
响应疟疾感染的呼吸组成的变化,在独立的位置。 2)相关
呼吸随寄生虫发育阶段而变化。我们的方法是创新的,因为我们会自然而然地注册
感染了该领域的儿童。儿童拥有最高的寄生虫和配子细胞密度。拟议的重新
搜索很重要,因为我们将在开发新的,急需的疟疾诊断工具方面发展
这不会依靠血液样本。
项目成果
期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Concordance of Upper and Lower Respiratory Tract Samples for SARS-CoV-2 in Pediatric Patients: Research Letter.
- DOI:10.1097/aln.0000000000003765
- 发表时间:2021-06-01
- 期刊:
- 影响因子:8.8
- 作者:Lin EE;Akaho EH;Sobilo A;Blatz AM;Otto WR;Odom John AR
- 通讯作者:Odom John AR
Volatile profiling distinguishes Streptococcus pyogenes from other respiratory streptococcal species.
- DOI:10.1128/msphere.00194-23
- 发表时间:2023-10-24
- 期刊:
- 影响因子:4.8
- 作者:Berna, Amalia Z.;Merriman, Joseph A.;Mellett, Leah;Parchment, Danealle K.;Caparon, Michael G.;Odom John, Audrey R.
- 通讯作者:Odom John, Audrey R.
Haloacid Dehalogenase Proteins: Novel Mediators of Metabolic Plasticity in Plasmodium falciparum.
- DOI:10.1177/1178636119848435
- 发表时间:2019-01-01
- 期刊:
- 影响因子:0
- 作者:Frasse, Philip M;Odom John, Audrey R
- 通讯作者:Odom John, Audrey R
The Malaria Metabolite HMBPP Does Not Trigger Erythrocyte Terpene Release.
- DOI:10.1021/acsinfecdis.0c00548
- 发表时间:2020-10-09
- 期刊:
- 影响因子:5.3
- 作者:Miller JJ;Odom John AR
- 通讯作者:Odom John AR
The Longest Mile: Moving Malaria from Clinical Care to Elimination of Transmission.
最长的一英里:将疟疾从临床护理转向消除传播。
- DOI:10.1373/clinchem.2019.303719
- 发表时间:2019
- 期刊:
- 影响因子:9.3
- 作者:Budge,PhilipJ;OdomJohn,AudreyR
- 通讯作者:OdomJohn,AudreyR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Audrey Ragan Odom John其他文献
Audrey Ragan Odom John的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Audrey Ragan Odom John', 18)}}的其他基金
FOSMIDOMYCIN RESISTANCE IN PLASMODIUM FALCIPARUM
恶性疟原虫对磷米霉素的耐药性
- 批准号:
10058237 - 财政年份:2019
- 资助金额:
$ 18.82万 - 项目类别:
FOSMIDOMYCIN RESISTANCE IN PLASMODIUM FALCIPARUM
恶性疟原虫对磷米霉素的耐药性
- 批准号:
10308079 - 财政年份:2019
- 资助金额:
$ 18.82万 - 项目类别:
FOSMIDOMYCIN RESISTANCE IN PLASMODIUM FALCIPARUM
恶性疟原虫对磷米霉素的耐药性
- 批准号:
10005586 - 财政年份:2019
- 资助金额:
$ 18.82万 - 项目类别:
FOSMIDOMYCIN RESISTANCE IN PLASMODIUM FALCIPARUM
恶性疟原虫对磷米霉素的耐药性
- 批准号:
8770021 - 财政年份:2012
- 资助金额:
$ 18.82万 - 项目类别:
MEP pathway resistance in Plasmodium falciparum
恶性疟原虫中的 MEP 途径耐药性
- 批准号:
10653457 - 财政年份:2012
- 资助金额:
$ 18.82万 - 项目类别:
FOSMIDOMYCIN RESISTANCE IN PLASMODIUM FALCIPARUM
恶性疟原虫对磷米霉素的耐药性
- 批准号:
9185927 - 财政年份:2012
- 资助金额:
$ 18.82万 - 项目类别:
FOSMIDOMYCIN RESISTANCE IN PLASMODIUM FALCIPARUM
恶性疟原虫对磷米霉素的耐药性
- 批准号:
8585818 - 财政年份:2012
- 资助金额:
$ 18.82万 - 项目类别:
FOSMIDOMYCIN RESISTANCE IN PLASMODIUM FALCIPARUM
恶性疟原虫对磷米霉素的耐药性
- 批准号:
8420970 - 财政年份:2012
- 资助金额:
$ 18.82万 - 项目类别:
FOSMIDOMYCIN RESISTANCE IN PLASMODIUM FALCIPARUM
恶性疟原虫对磷米霉素的耐药性
- 批准号:
8968811 - 财政年份:2012
- 资助金额:
$ 18.82万 - 项目类别:
相似国自然基金
面向掌纹识别的安全与隐私保护理论和方法研究
- 批准号:62376211
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
微观市场均衡视角下中国长期护理保险试点的福利分析与政策评估
- 批准号:72304093
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向康复护理机器人的人机信任度评估方法与任务影响机制研究
- 批准号:62306195
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于生命质量的癌症患者心理行为与护理干预
- 批准号:72381240026
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:国际(地区)合作与交流项目
天然水体中药品和个人护理品间接光降解产物预测模型的构建和应用
- 批准号:42307496
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Computer Vision for Malaria Microscopy: Automated Detection and Classification of Plasmodium for Basic Science and Pre-Clinical Applications
用于疟疾显微镜的计算机视觉:用于基础科学和临床前应用的疟原虫自动检测和分类
- 批准号:
10576701 - 财政年份:2023
- 资助金额:
$ 18.82万 - 项目类别:
Quantifying the dual threat of Plasmodium vivax and Anopheles stephensi in a P. falciparum endemic pre-elimination setting in sub-Saharan Africa
量化撒哈拉以南非洲恶性疟原虫地方性预消灭环境中间日疟原虫和斯氏按蚊的双重威胁
- 批准号:
10726003 - 财政年份:2023
- 资助金额:
$ 18.82万 - 项目类别:
Delineating host, parasite and pharmacologic factors impacting the treatment of malaria in children with and without HIV
描述影响感染和未感染艾滋病毒儿童疟疾治疗的宿主、寄生虫和药理学因素
- 批准号:
10700089 - 财政年份:2022
- 资助金额:
$ 18.82万 - 项目类别:
Improving Neonatal health Through Rapid malaria testing in Early Pregnancy with high-sensitivity Diagnostics (INTREPiD)
通过妊娠早期快速疟疾检测和高灵敏度诊断来改善新生儿健康 (INTREPiD)
- 批准号:
10405395 - 财政年份:2022
- 资助金额:
$ 18.82万 - 项目类别:
Delineating host, parasite and pharmacologic factors impacting the treatment of malaria in children with and without HIV
描述影响感染和未感染艾滋病毒儿童疟疾治疗的宿主、寄生虫和药理学因素
- 批准号:
10539863 - 财政年份:2022
- 资助金额:
$ 18.82万 - 项目类别: